1/21
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
What should be considered when looking at which treatment should be used? (1→3, 1→1, 1→1)
Effectiveness
Does the treatment work?
How does it work?
For whom does it work?
Efficacy
Does it help?
Efficiency
Cost-benefit ratio
Why is it important to make clinical actions explicit?
Communication
All involved parties know clearly what will occur
11 step basic treatment plan (Wilson et al., 2003)
Specify the behaviour to be changed
Decide whether an operational def is required
State treatment goals/aims
Measure the problem (baseline measurement)
Consider motivators/reinforcers
Plan treatment
Begin treatment
Monitor treatment progress
Evaluate treatment
Change if necessary
Plan for generalisation
Example with 11 steps
Specify the behaviour to be changed: perseveration
Decide whether an operational def is required: repeating a word/action/thought long after it is appropriate/relevant
State treatment goals/aims: apply relevant word/action/thought during context switching
Measure the problem (baseline measurement): time how long it takes to use correct/appropriate word/action/thought
Consider motivators/reinforcers: specific positive feedback + reminders when perseveration continues
Plan treatment
Begin treatment
Monitor treatment progress: measure every day
Evaluate treatment: evaluate fortnightly
Change if necessary: adjust goals (more or less ambitious)
Plan for generalisation: to real world settings, e.g. conversations
Example for step 5
Use specific positive feedback
Example for step 6
Who, when, where, how often, which strategies
Evidence-based medicine (EBM): factors considered (4)
Clinical research literature
Pathophysiology understanding
Clinical experience
Patient preferences
Diagram of how EBM is used in clinical decision-making + 2 notes
Patients have more say in decision-making now (collaborative decision-making)
Search for evidence, evaluate quality

What can undermine EBM? (1)
When professionals stick to their own habits/rules/practices rather than considering + implementing what the most recent research suggests would be suitable
Randomised control description (3)
Random assignment to control + experimental group
Control → placebo, experimental → treatment
Double blind (patients + researchers don’t know who is receiving treatment)
What are RCTs generally used for?
Studying treatment efficacy
Single-case experimental design (SCED) description (1, 1→2)
One participant/series of participants is experimentally studied
Measure baseline, then measure during intervention, then maybe after
So patient acts as their own control
When are SCEDs used? (2)
Rare cases
High variability in interest population
What does the power of SCEDs lie in? (1)
The number of measurements, rather than the number of participants
How can the external validity of SECDs be increased? (1)
By replicating the design with more participants
How are SCEDs viewed/considered? Note?
Usually considered lower quality research than RCTs, systematic reviews + meta-analyses
However, SCEDs are now ranked as level 1 research by the Oxford Centre for EBM
How can clinicians consider evidence from all the available research to date?
By looking at evidence-based guidelines, which are written by experts who have synthesised evidence from journal articles
Examples of organisations/bodies that write evidence-based guidelines (3)
American Heart Associations
Australian National Health and Medical Research Council (NHMRC)
INCOG (write neuropsych guidelines)
Economic evaluation def
Comparing costs + consequences of possible courses of action
Examples of economic evaluation w brief description (2)
Cost-benefit analysis: monetary benefit from treatment vs no treatment
Cost-effectiveness analysis: compares treatment A to treatment B based on natural clinical outcomes such as “cost per additional year of life gained”
Which types of interventions are of specific interest in the field of economic evaluation + why?
Self-management interventions
Cost-effective for more than one population
Chronic disease (including acquired brain injury)
Due to high social + financial burden
Considerations in evidence-based practice (3)
Does the treatment work?
Does the treatment help this patient (aligning with their specific goals)?
What are the costs/benefits?